Kymera Therapeutics, Inc. (KYMR)

91.35 -3.68 (-3.87%) USD  |  NASDAQ  |  Feb 27, 16:00
91.37 +0.02 (+0.02%) After-Hours: 20:00
More

Kymera Therapeutics Quarterly Revenue Estimates

Quarterly Revenue Estimates Chart

View Quarterly Revenue Estimates for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Quarterly Revenue Estimates Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Quarterly Revenue Estimates Range, Past 5 Years

View Quarterly Revenue Estimates Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Quarterly Revenue Estimates Benchmarks

View Quarterly Revenue Estimates Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Revolution Medicines, Inc. Upgrade
Structure Therapeutics, Inc. Upgrade
Sanofi Upgrade